| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.87▲ | 9.87▲ | 9.87▲ | 9.87▼ | 9.87▲ |
| MA10 | 9.87▼ | 9.87▼ | 9.88▼ | 9.87▲ | 9.88▼ |
| MA20 | N/A | N/A | N/A | 9.87▲ | N/A |
| MA50 | N/A | N/A | N/A | 9.88▼ | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | 0.001▲ | N/A |
| RSI | 56.667▲ | 56.250▲ | 56.250▲ | 48.539▼ | N/A |
| STOCH | N/A | N/A | N/A | 65.278 | N/A |
| WILL %R | -71.429 | -71.429 | -71.429 | -50.000 | N/A |
| CCI | -60.317 | -60.317 | -46.009 | 44.537 | N/A |
|
Thursday, October 29, 2026 05:01 PM
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
|
|
Thursday, October 29, 2026 03:45 AM
Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced in Q3 2026, but revenue fell by 1.4% year on year to $691.5 million. The company’s full-year revenue guidance of $2.68 billion at the ...
|
|
Thursday, October 29, 2026 03:45 AM
Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q3 2026, but revenue fell by 1.4% year on year to $691.5 million. The company’s full-year revenue ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/26 | 9.88 | 9.88 | 9.87 | 9.87 | 16,211 |
| 29/10/26 | 9.88 | 9.88 | 9.88 | 9.88 | 166 |
| 28/10/26 | 9.87 | 9.87 | 9.87 | 9.87 | 162 |
| 27/10/26 | 9.87 | 9.87 | 9.87 | 9.87 | 0 |
| 26/10/26 | 9.87 | 9.87 | 9.87 | 9.87 | 0 |
| 23/10/26 | 9.87 | 9.87 | 9.865 | 9.865 | 319 |
| 22/10/26 | 9.87 | 9.87 | 9.87 | 9.87 | 304,728 |
| 21/10/26 | 9.87 | 9.87 | 9.86 | 9.86 | 2,213 |
| 20/10/26 | 9.865 | 9.87 | 9.865 | 9.87 | 432 |
| 19/10/26 | 9.865 | 9.865 | 9.865 | 9.865 | 40,217 |
|
|
||||
|
|
||||
|
|